You are here

Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Beiser, Alexa S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Spartano NL, Demissie S, Himali JJ, Dukes KA, Murabito JM, Vasan RS, Beiser AS, Seshadri S.  2019.  Accelerometer-determined physical activity and cognitive function in middle-aged and older adults from two generations of the Framingham Heart Study.. Alzheimers Dement (N Y). 5:618-626.
Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, Pase MP, Himali JJ, B Windham G, Griswold M et al..  2020.  Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies.. Lancet Neurol. 19(1):61-70.
Spartano NL, Davis-Plourde KL, Himali JJ, Andersson C, Pase MP, Maillard P, DeCarli C, Murabito JM, Beiser AS, Vasan RS et al..  2019.  Association of Accelerometer-Measured Light-Intensity Physical Activity With Brain Volume: The Framingham Heart Study.. JAMA Netw Open. 2(4):e192745.
Pase MP, Himali JJ, Beiser AS, DeCarli C, McGrath ER, Satizabal CL, Aparicio HJ, Adams HHH, Reiner AP, Longstreth WT et al..  2020.  Association of CD14 with incident dementia and markers of brain aging and injury.. Neurology. 94(3):e254-e266.
Weinstein G, Davis-Plourde KL, Conner S, Himali JJ, Beiser AS, Lee A, Rawlings AM, Sedaghat S, Ding J, Moshier E et al..  2019.  Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts.. PLoS One. 14(2):e0212293.
Weinstein G, Davis-Plourde K, Beiser AS, Seshadri S.  2021.  Autonomic Imbalance and Risk of Dementia and Stroke: The Framingham Study.. Stroke. 52(6):2068-2076.
C
Peloso GM, Beiser AS, Satizabal CL, Xanthakis V, Vasan RS, Pase MP, DeStefano AL, Seshadri S.  2020.  Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study.. Neurology. 95(10):e1341-e1350.
McGrath ER, Himali JJ, Xanthakis V, Duncan MS, Schaffer JE, Ory DS, Peterson LR, DeCarli C, Pase MP, Satizabal CL et al..  2020.  Circulating ceramide ratios and risk of vascular brain aging and dementia.. Ann Clin Transl Neurol.
McGrath ER, Himali JJ, Levy D, Conner SC, Pase MP, Abraham CR, Courchesne P, Satizabal CL, Vasan RS, Beiser AS et al..  2019.  Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.. PLoS One. 14(3):e0213321.
Georgakis MK, Malik R, Björkbacka H, Pana TAlexandru, Demissie S, Ayers C, Elhadad MA, Fornage M, Beiser AS, Benjamin EJ et al..  2019.  Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals.. Circ Res. 125(8):773-782.
Raman MR, Himali JJ, Conner SC, DeCarli C, Vasan RS, Beiser AS, Seshadri S, Maillard P, Satizabal CL.  2018.  Circulating Vascular Growth Factors and Magnetic Resonance Imaging Markers of Small Vessel Disease and Atrophy in Middle-Aged Adults.. Stroke. 49(9):2227-2229.
Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, Yanek LR, Wen W, Gudnason VG, Dueker ND et al..  2020.  Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.. Stroke. 51(7):2111-2121.

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer